Filter Results:
(469)
Show Results For
- All HBS Web
(705)
- News (190)
- Research (469)
- Events (1)
- Multimedia (24)
- Faculty Publications (437)
Show Results For
- All HBS Web
(705)
- News (190)
- Research (469)
- Events (1)
- Multimedia (24)
- Faculty Publications (437)
Sort by
- August 2012 (Revised August 2012)
- Case
HealthAllies (A)
By: Regina E. Herzlinger and Michael Sherman
This case describes a "do good and do well" firm that enables individuals to buy health care services at discounted prices. It delineates the characteristics of the uninsured and others who are the primary targets for the firm. "HealthAllies (B)" provides information... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Marketing Channels; Demand and Consumers; Commercialization; Health Industry
Herzlinger, Regina E., and Michael Sherman. "HealthAllies (A)." Harvard Business School Case 302-019, August 2012. (Revised from original August 2001 version.)
- January 2010 (Revised August 2012)
- Supplement
Hospital for Special Surgery (B): Continuing Challenges of Growth
By: Regina E. Herzlinger and Laura Low Ah Kee
After its successful new U.K. venture, the Hospital for Special Surgery wants to do more of the same, without decimating its core New York City facility. The case provides considerable details about the different options it is exploring. View Details
Herzlinger, Regina E., and Laura Low Ah Kee. "Hospital for Special Surgery (B): Continuing Challenges of Growth." Harvard Business School Supplement 310-077, January 2010. (Revised August 2012.)
- Article
Cross Country: They'd Sooner Fix Medicaid
By: Tom Coburn and Regina Herzlinger
Coburn, Tom, and Regina Herzlinger. "Cross Country: They'd Sooner Fix Medicaid." Wall Street Journal (May 18, 2006).
- 19 Jun 2012
- First Look
First Look: June 19
Navalny the right figure for business leaders in Russia to organize around? What were the risks of getting involved with a politically volatile activist? Purchase this case:http://cb.hbsp.harvard.edu/cb/product/112033-PDF-ENG McKesson View Details
Keywords: Sean Silverthorne
- November 26, 2003
- Article
Back in the U.S.S.R
By: R. E. Herzlinger
Herzlinger, R. E. "Back in the U.S.S.R." Wall Street Journal (November 26, 2003), A16.
- 06 Mar 2013
- Research & Ideas
HBS Cases: Women MBAs at Harvard Business School
product." A Class of 1973 alumna recalls professors "who, in the middle of a class, would look at the women and the African Americans and say, 'Is this too difficult for you?' " By 1985 women made up 25 percent of the graduating MBA class and Professor... View Details
- Article
U.S. Economic Revolution: Mapping the Future of Healthcare
By: R. E. Herzlinger
Herzlinger, R. E. "U.S. Economic Revolution: Mapping the Future of Healthcare." PharmacoEconomics 18, suppl. 1 (December 2000).
- 1992
- Book
Creating New Health Care Ventures: The Role of Management
By: R. E. Herzlinger
Herzlinger, R. E. Creating New Health Care Ventures: The Role of Management. Gaithersburg, MD: Aspen Publishing, 1992.
- August 9, 1997
- Article
Hamburgers and Hernias
By: R. E. Herzlinger
Herzlinger, R. E. "Hamburgers and Hernias." Economist (August 9, 1997).
- January 22, 2004
- Article
More Market, Less Straightjacket
By: R. E. Herzlinger
Keywords: Markets
Herzlinger, R. E. "More Market, Less Straightjacket." Wall Street Journal (January 22, 2004), A12.
- April 2, 2003
- Article
My Ivy League Soldier
By: R. E. Herzlinger
Herzlinger, R. E. "My Ivy League Soldier." Wall Street Journal (April 2, 2003), A14.
- June 13, 2003
- Article
Prix-Fix Rip-Off
By: R. E. Herzlinger
Herzlinger, R. E. "Prix-Fix Rip-Off." Wall Street Journal (June 13, 2003), A6.
- 1999
- Chapter
Can Public Trust in Nonprofits and Governments Be Restored?
By: R. E. Herzlinger
Herzlinger, R. E. "Can Public Trust in Nonprofits and Governments Be Restored?" In Harvard Business Review on Nonprofits. Boston, MA: Harvard Business School Press, 1999.
- September 2012 (Revised August 2014)
- Background Note
Note on Radiation Therapy, Stereotaxis, and Stereotactic Radiosurgery
By: Regina E. Herzlinger, Regina E. Herzlinger, T. Forcht Dagi and T. Forcht Dagi
Herzlinger, Regina E., and T. Forcht Dagi. "Note on Radiation Therapy, Stereotaxis, and Stereotactic Radiosurgery." Harvard Business School Background Note 313-073, September 2012. (Revised August 2014.)
- December 2023
- Article
Association of Hospital System Affiliation with COVID-19 Capacity Burden
By: Zachary Levin, Pinar Karaca-Mandic, Richard J. Boxer and Regina E. Herzlinger
What is the message? The COVID-19 pandemic exposed the highly variable and uncoordinated responses by hospitals. The authors found that while the non-top ten system affiliated hospitals had a larger COVID-19 share index relative to independent hospitals, top-ten system... View Details
Keywords: COVID-19 Pandemic; Resource Allocation; Health Pandemics; Demographics; Health Care and Treatment; Health Industry
Levin, Zachary, Pinar Karaca-Mandic, Richard J. Boxer, and Regina E. Herzlinger. "Association of Hospital System Affiliation with COVID-19 Capacity Burden." Health Management, Policy and Innovation 8, no. 3 (December 2023).
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
game is supposed to be quality up and cost down. And this is one where that has not happened. And it's been very slow with the quality movement." Professor Regina Herzlinger, who has studied the health care system for three decades,... View Details
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- August 2012 (Revised January 2013)
- Module Note
Note on Pharmaceutical Reimbursement in the U.S.
By: Regina Herzlinger and Drew Cronin-Fine